B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

To know 8-year-old Brielle Ambabo is to love her. Her silly personality, upbeat attitude and countless jokes are sure to ...

Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Zavier Sexton, Graham Smith, Bryce Miller and Natalie Vulhop were honored as young heroes at the 2025 CBJ Foundation ...

A young girl from Amsterdam has died after a long hard-fought battle with leukemia.10-year-old Portia Robles died Saturday ...

These innovations have turned many leukemia types from fatal diagnoses to manageable conditions. The five-year survival rate for all leukemia types combined has increased from 34% in the 1970s to ...

Imagine one day of your life, completely normal. And the next – your entire life is dedicated to your child’s survival.